Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Sexually transmitted infections epidemiology news

Show

From To
English clinic survey finds that 40% of gay men with new hepatitis C infections are HIV negative

A study of gay and bisexual men diagnosed with recently acquired hepatitis C infection and treated in three English clinics has found that 40% of them were

Published
07 April 2019
By
Gus Cairns
First year of PrEP in Scotland: more users than expected, few dropouts, few HIV infections

The recent report on the first year of the implementation of  pre-exposure prophylaxis (PrEP) through the National Health Service (NHS) in Scotland concludes: “Year one has

Published
02 April 2019
By
Gus Cairns
Women Have High Syphilis Rates, Too

For women in the general population, the incidence of syphilis is at a 20-year high. But for women with HIV — particularly those who inject drugs — the incidence is 330% higher than that, data from a long-term study show. The biggest indicators of syphilis in women are hepatitis C infection and injection drug use. This means that providers should tailor syphilis screening to women with indicators of injection drug use, particularly in regions of the country hardest hit by injection drug epidemics.

Published
11 March 2019
From
Medscape (requires free registration)
Gonorrhoea: drug resistance compromises recommended treatment in Europe

In 2017, 27 EU/EEA countries collected and tested 3 248 gonococcal isolates which revealed that cefixime and azithromycin resistance (1.9% and 7.5% respectively) remained unchanged compared to 2016 (2.1% and 7.5%). However, the number of countries reporting resistant isolates for each antimicrobial increased. For the second year in a row, no isolates with resistance to ceftriaxone were detected in contrast to one in 2015, five in 2014 and seven in 2013.

Published
28 February 2019
From
ECDC
US: STIs Drive 1 in 10 HIV Transmissions in Gay & Bi Men

Chlamydia and gonorrhea make untreated HIV more transmittable and make HIV-negative people more susceptible to contracting the virus.

Published
04 February 2019
From
Poz
26% of black MSM in PrEP trial diagnosed with STI during follow-up

More than 26% of black men who have sex with men, or MSM, who were enrolled in a pre-exposure prophylaxis, or PrEP, trial were diagnosed with an STI in follow-up, and younger study participants had higher rates of STIs than older participants, according to research published in Clinical Infectious Diseases.

Published
14 January 2019
From
Healio
Meta-analysis finds high but variable STI rates in PrEP studies – is PrEP the cause or a potential solution?

A new meta-analysis of 20 studies and roll-out projects of HIV pre-exposure prophylaxis (PrEP) in gay and bisexual men confirms very high rates of diagnosis of sexually

Published
11 January 2019
By
Gus Cairns
Public Health England warns that improved treatment and testing rates for STIs in the UK could be imperilled by cuts

A review of one hundred years of diagnoses of sexually transmitted infections (STIs) in the UK confirms that there have been sharp increases in gonorrhoea and syphilis

Published
18 December 2018
By
Gus Cairns
Stop blaming PrEP for the rise in STIs – the picture is more complex than that

When MSM seek out PrEP, it is a decision that should be supported. To castigate them is to increase stigma and discourage their engagement with health services. We must encourage PrEP use, accept that condom use may fall as a result, design supportive care and be happy knowing that every averted HIV infection is a life-altering moment.

Published
10 December 2018
From
The Conversation
The unexpected effects of the HIV prevention pill

PrEP is great at blocking HIV, but as its use grows, so do fears that people will be more sexually reckless and spread other STIs. But researchers are coming to think that the opposite could be true.

Published
29 November 2018
From
Mosaic
← First12345...22Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.